| Today's News and Trends | The shift follows a paper published by the FDA in the New England Journal of Medicine last week, outlining a stricter framework for approving annual COVID-19 boosters and future vaccines. The shift follows a paper published by the FDA in the New England Journal of Medicine last week, outlining a stricter framework for approving annual COVID-19 boosters and future vaccines. | | |
| The Digital Medicine Society has partnered with organizations such as Duke University and Google Fitbit to leverage wearable technology and smartphone data in reducing opioid relapse and overdose deaths. As the pilot study gets underway, HealthExec speaks with Candice Taguibao, associate program director at the Digital Medicine Society, to learn more about the initiative. The Digital Medicine Society has partnered with organizations such as Duke University and Google Fitbit to leverage wearable technology and smartphone data in reducing opioid relapse and overdose deaths. As the pilot study gets underway, HealthExec speaks with Candice Taguibao, associate program director at the Digital Medicine Society, to learn more about the initiative. | | |
| | A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions. A serious issue with esophagogastric balloon tamponade tubes manufactured by BD could cause the devices to break, potentially delaying care for bleeding patients. Clinicians are advised to review and follow updated use instructions. | | |
| The lawsuits, filed in multiple states, contend there's a causal link between semaglutide and a rare condition called NAION that leads to diminished eyesight. Plaintiffs want the popular weight-loss drugs to add a warning label. The lawsuits, filed in multiple states, contend there's a causal link between semaglutide and a rare condition called NAION that leads to diminished eyesight. Plaintiffs want the popular weight-loss drugs to add a warning label. | | |
| The Centers for Medicare & Medicaid Services is updating the ACO REACH program—which supports providers caring for rural and low-income populations—to promote patient health as a strategy to reduce costs. The Centers for Medicare & Medicaid Services is updating the ACO REACH program—which supports providers caring for rural and low-income populations—to promote patient health as a strategy to reduce costs. | | |
| | State Attorney General Dana Nessel is suing Express Scripts and Prime Therapeutics, accusing the two PBMs of manipulating rebate pricing, "crippling small, independent pharmacies and restricting access to lifesaving medications in the process." State Attorney General Dana Nessel is suing Express Scripts and Prime Therapeutics, accusing the two PBMs of manipulating rebate pricing, "crippling small, independent pharmacies and restricting access to lifesaving medications in the process." | | |
| The states argue the Department of Health and Human Services is failing to perform basic functions, in violation of the Constitution, as the agency and its programs are authorized by Congress. The states argue the Department of Health and Human Services is failing to perform basic functions, in violation of the Constitution, as the agency and its programs are authorized by Congress. | | |
| | Known to increase fatigue and impact performance, traditional call models for nighttime IR coverage contribute to burnout and gaps in patient care. Known to increase fatigue and impact performance, traditional call models for nighttime IR coverage contribute to burnout and gaps in patient care. | | |
| Healthcare AI can add considerable value to patient care practices, but it can also “just add noise to an already complex system.” Healthcare AI can add considerable value to patient care practices, but it can also “just add noise to an already complex system.” | | |
| |
|
| ![]() | |
|
